{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:59:31Z","timestamp":1778695171247,"version":"3.51.4"},"reference-count":30,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Actinic keratoses (AK) are increasing in incidence and represent the most common (pre\u2010)cancerous lesion in the fair\u2010skinned population, with a high unmet medical need. In order to increase treatment adherence, it is very important to assess patients' therapy\u2010related evaluations of different treatment options.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and methods<\/jats:title><jats:p>100 patients with AK who were treated with at least two different treatment options were included. They rated their therapies using the Treatment Satisfaction Questionnaire for Medication (TSQM, maximum 100 points per category) and a Likert scale (LS, 1\u00a0 = \u00a0very satisfied; 6\u00a0 = \u00a0not satisfied). Patients were also asked about their needs in terms of treatment goal, cost, type, duration, and location of treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>81% of the study participants were male and on average 74 years old. 95% had field cancerization. Eight frequently used therapy procedures were evaluated by the patients (surgery, cryotherapy, various topical agents, photodynamic therapy). The TSQM satisfaction scores ranged from 78.47 \u00b1\u00a016.07 (surgical procedures) to 53.03 \u00b1\u00a022.13 (diclofenac\u2010HA). Statistically significant differences between the procedures were only found in the area of efficacy. Side effects were classified as low. Low recurrence rate and safe removal were the most important treatment goals (LS: 1.18 \u00b1\u00a00.44 and 1.27 \u00b1\u00a00.53, respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Understanding patient preferences is essential for adherence and is therefore of great importance for the success of AK therapy. Personalized approaches should be considered in the choice of therapy.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ddg.15457","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T16:04:00Z","timestamp":1724342640000},"page":"1362-1368","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["If patients had a choice \u2013 Treatment satisfaction and patients\u2019 preference in therapy of actinic keratoses"],"prefix":"10.1111","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4679-3777","authenticated-orcid":false,"given":"Berenice M.","family":"Lang","sequence":"first","affiliation":[{"name":"Department of Dermatology University Medical Center Mainz  Mainz Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Zielbauer","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Medical Center Mainz  Mainz Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henner","family":"Stege","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Medical Center Mainz  Mainz Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Grabbe","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Medical Center Mainz  Mainz Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Staubach","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Medical Center Mainz  Mainz Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-18486-4_1"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-014-2759-6"},{"key":"e_1_2_7_4_1","first-page":"154","article-title":"Prevalence of solar damage and actinic keratosis in a Merseyside population","volume":"42","author":"Memon AA","year":"2001","journal-title":"Br J Dermatol"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.12415"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2023.108226"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00761-017-0189-7"},{"key":"e_1_2_7_8_1","first-page":"29","article-title":"How to treat actinic keratosis? An update","volume":"2","author":"Costa C","year":"2015","journal-title":"J Dermatol Case Rep"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10204736"},{"key":"e_1_2_7_10_1","first-page":"30","article-title":"Compliance und Persistence \u2010 patientenorientierte Ma\u00dfnahmen","volume":"05","author":"Patientenadh\u00e4renz Esberger\u2010Chowdhury M.","year":"2015","journal-title":"PharmAustria"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2015.89"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S24752"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-2-12"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2005.00066.x"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1994.tb01167.x"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-019-3696-6"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-020-04731-y"},{"key":"e_1_2_7_18_1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/ddg.14048","article-title":"S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma \u2010 short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality\u2010of\u2010care indicators","volume":"18","author":"Heppt MV","year":"2020","journal-title":"J Dtsch Dermatol Ges"},{"key":"e_1_2_7_19_1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/ddg.14072","article-title":"S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) \u2010 short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow\u2010up, prevention and occupational disease","volume":"18","author":"Leiter U","year":"2020","journal-title":"J Dtsch Dermatol Ges"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1159\/000381420"},{"key":"e_1_2_7_21_1","first-page":"26","article-title":"Three\u2010Day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: Cosmetic Outcomes and Patient Satisfaction from a Phase II Trial","volume":"10","author":"Berman B","year":"2017","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.01.036"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1329514"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14691"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15142"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.10098.x"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/14764170802056117"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811850"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.08.076"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051438"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2016.1254328"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ddg.15457","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T07:11:21Z","timestamp":1756969881000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ddg.15457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1111\/ddg.15457"],"URL":"https:\/\/doi.org\/10.1111\/ddg.15457","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]},"assertion":[{"value":"2024-01-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}